Divi’s Laboratories Limited is a Company limited by shares, incorporated and domiciled in India. The Company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. The Company is a public limited company and the Company’s equity shares are listed in BSE Limited (BSE) and National Stock Exchange of India Limited (NSE) in India.
Business area of the company
The Company manufactures Generic APIs, Nutraceutical Ingredients and offers Custom Synthesis of APIs to Big Pharma providing a competitive advantage over the entire life cycle of the products.
Business Segments
Generic APIs
Custom Synthesis
Nutraceuticals
Products
Capecitabine
Carbidopa
Diltiazem HCl
Dextromethorphan Base
Dextromethorphan HBr
Fosphenytoin Sodium
Gabapentin
Iopamidol
Irbesartan
Levetiracetam
Levodopa
Mesalamine
Nabumetone
Naproxen
Naproxen Sodium
Niacin
Olmesartan Medoxomil
Phenylephrine HCl
Pregabalin
Proguanil HCl
Quetiapine Fumarate
Tamsulosin HCl
Telmisartan
Triprolidine HCl
Valacyclovir HCl
Valsartan
Venlafaxine HCl
Vigabatrin
Awards
2001:
2002:
2003:
Shreshtha Suraksha Puraskar
Appreciation certificate for Meritorious performance in implementing the programmes of ‘Safe Guarding the Environment and Pollution Control’
Viswakarma Rashtriya Puraskar
2004:
2005:
National Award for Excellence Water Management 2005
Appreciation certificate for Meritorious performance in implementing the programmes of ‘Safe Guarding the Environment and Pollution Control & Plantation work’.
May Day Award for Best Management
2006:
National Award for Excellence Water Management and Certificate for Water efficient unit.
National Award for Excellence Water Management and Certificate for Water efficient unit - Beyond the fence.
Appreciation certificate for ‘Best Cleaner Production Practices and Waste Minimization Techniques’.
2007:
2008:
2009:
Certified and Awarded for ‘Best Green Belt Development’
Occupational Health and Safety Management System (OHSAS-18001:2007)
ISO 14001: 2004 (Re-Certification) ‘Environment Management System’
2011:
2012:
India Business Leader Award ‘First Generation Entrepreneur of the Year’
Occupational Health and Safety Management System OHSAS 1800:2007 (Re-certification)
ISO 14001: 2004 (Re-Certification) ‘Environment Management System’.
2013:
2014:
2015:
Occupational Health and Safety Management System OHSAS 1800:2007 (Re-certification)
May Day award for Best Management
ISO 14001: 2004 (Re-Certification) ‘Environment Management System’.
2018:
Occupational Health and Safety Management System OHSAS 1800:2007 (Re-certification)
ISO 14001 : 2018 (Re- certification) ‘Environmental Management System’.
May Day award for Best Management
Milestones
1990: Inception of Divi’s as Divi’s Research Centre(DRC)
1995: Setup First Manufacturing facility(Unit-1) near Hyderabad
2000: First USFDA Inspection
2002: Commenced New Manufacturing Facility (Unit 2) near Vishakhapatnam
2003: Divi’s Labs listed on Indian Stock Exchange
2007: Set up Nutraceuticals facility at Unit 2
2008: First MFDS(Korea) inspection
2010: Established New Research Centre at Hyderabad
2011: First EU GMP and Japan PMDA Inspection
2012: First TGA Inspection
2013: First Slovenian Medicines Agency inspection for Unit-II
2014: Divi’s reaches a milestone of 8700 employees
2014: First COFEPRIS inspection
2015: New corporate office inaugurated at Hyderabad
2015: New Pilot block with 160 Reactors and Kilo Lab
2016: First Anvisa (Brazil) inspection
2017: Divi’s reaches a milestone of 11,000 employees and becomes one of the largest employers in the combined state of Telangana/Andhra Pradesh
2017: Reaches the milestone of being one among the top 3 API manufacturers in the world and one among the top API companies in Hyderabad
2018: Market capital of $5B Reached
2018: 10 new production blocks commissioned
2018: Expanded the product portfolio to over 30 products
2019: Setting up Manufacturing plant at Kakinada
2019: Additional investment of $250M towards expansion of production blocks in Unit -I and Unit- II
Comment